Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Novo Integrated Sciences Inc (NVOS)

  • Technical Exchange News
  • Nov. 06, 2024, 00:13 UTC
  • 54
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Novo Integrated Sciences, Inc. - Common Stock.

Comment Full text

Novo Integrated Sciences Inc (NVOS)

  • Technical Exchange News
  • Nov. 05, 2024, 18:38 UTC
  • 51
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Genprex Inc. (GNPX)

  • Technical Exchange News
  • Nov. 05, 2024, 18:38 UTC
  • 48
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Allakos Inc (ALLK)

  • Technical Exchange News
  • Nov. 05, 2024, 18:37 UTC
  • 46
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Universe Pharmaceuticals Inc. (UPC)

  • Technical Exchange News
  • Nov. 02, 2024, 02:04 UTC
  • 50
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Universe Pharmaceuticals Inc. (UPC)

  • Technical Exchange News
  • Nov. 01, 2024, 19:10 UTC
  • 45
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Nexalin Technology Inc (NXL)

  • Technical Exchange News
  • Nov. 01, 2024, 03:54 UTC
  • 42
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cellectar Biosciences Inc. (CLRB)

  • Technical Exchange News
  • Nov. 01, 2024, 03:53 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

BioSig Technologies Inc. (BSGM)

  • Technical Exchange News
  • Nov. 01, 2024, 03:53 UTC
  • 42
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Nexalin Technology Inc (NXL)

  • Technical Exchange News
  • Oct. 31, 2024, 21:12 UTC
  • 46
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 322
  • 323
  • 324
  • 325
  • 326
  • Next

Search

News categories

  • Technical Exchange News(10905)
  • Event(2316)
  • SEC News(190465)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124863)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin